title: A preliminary experience with the HyperCHiDAM Verona intensive chemotherapy regimen in heavily pretreated refractory Hodgkin's lymphoma.
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Todeschini
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Bonifacio
authors.forename: Cristina
authors.initials: C
authors.lastname: Tecchio
authors.forename: Daniela
authors.initials: D
authors.lastname: Dalceggio
authors.forename: Fabio
authors.initials: F
authors.lastname: Benedetti
authors.forename: Attilio
authors.initials: A
authors.lastname: Gabbas
authors.forename: Giovanni
authors.initials: G
authors.lastname: Pizzolo
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D016879:Salvage Therapy; D055815:Young Adult
chemical_list: D003561:Cytarabine; D003520:Cyclophosphamide; D008727:Methotrexate